Lumiracoxib
10mM in DMSO
- Product Code: 201950
CAS:
220991-20-8
| Molecular Weight: | 293.72 g./mol | Molecular Formula: | C₁₅H₁₃ClFNO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD07186254 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used primarily in the treatment of osteoarthritis and rheumatoid arthritis, this compound acts as a selective COX-2 inhibitor, providing anti-inflammatory and analgesic effects with reduced risk of gastrointestinal side effects compared to non-selective NSAIDs. It has been investigated for managing acute postoperative pain and dysmenorrhea due to its potent pain-relieving properties. Although withdrawn in several markets due to safety concerns, it demonstrated efficacy in reducing joint pain and inflammation in short-term clinical use.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | $183.89 |
+
-
|
Lumiracoxib
Used primarily in the treatment of osteoarthritis and rheumatoid arthritis, this compound acts as a selective COX-2 inhibitor, providing anti-inflammatory and analgesic effects with reduced risk of gastrointestinal side effects compared to non-selective NSAIDs. It has been investigated for managing acute postoperative pain and dysmenorrhea due to its potent pain-relieving properties. Although withdrawn in several markets due to safety concerns, it demonstrated efficacy in reducing joint pain and inflammation in short-term clinical use.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :